Publication

On July 15-16, 2014, the Sustainable Predictive Oncology Therapeutics and Diagnostics Working Group (SPOT/Dx) convened its third meeting in Arlington, Virginia. Please see the Appendix for a list of meeting participants. The group reaffirmed its commitment to cancer patients, outlined a pilot focused on enhancing the quality of future molecular diagnostics, continued to explore the merits of facilitated drug access/outcomes registry programs, and considered what future contribution the SPOT/Dx group could make to accelerate and safeguard the implementation of precision medicine in oncology.